KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News
KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.
AliveCor gains US FDA clearance for KardiaMobile 6L to calculate patients' QTc interval - Medical Device News by Guided Solutions
AliveCor gains US FDA clearance for KardiaMobile 6L to calculate patients' QTc interval - Medical Device News by Guided Solutions
COVID-19 Archives - Cardiac Rhythm News
A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
Implementation of a fully remote randomized clinical trial with cardiac monitoring
Implementation of a fully remote randomized clinical trial with cardiac monitoring
A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young
Implementation of a fully remote randomized clinical trial with cardiac monitoring
Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review - Heart Rhythm
Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement - Lenihan - 2020 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Sensors, Free Full-Text
Artificial Intelligence–Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device
2021 ISHNE/HRS/EHRA/APHRS collaborative statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals - Varma - 2021 - Journal of Arrhythmia - Wiley Online Library
